E2F2 and ovarian carcinoma: In the 655 patients with ovarian cancer in the Kaplan–Meier Plotter database12,17, a higher E2F2 expression level was significantly associated with poorer PFS and OS values (vs. lower E2F2 expression) (Fig. 5G).